Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer drug holds promise as a new treatment for neurodegenerative diseases

Cancer drug holds promise as a new treatment for neurodegenerative diseases

Leukemia cells depend on P-bodies for growth and survival

Leukemia cells depend on P-bodies for growth and survival

SwRI develops a unique technology to screen new DNA-targeting therapeutics

SwRI develops a unique technology to screen new DNA-targeting therapeutics

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

New genomic predictors of relapse in childhood B-cell acute lymphoblastic leukemia uncovered

New genomic predictors of relapse in childhood B-cell acute lymphoblastic leukemia uncovered

Breakthrough discovery could boost stem-cell transplants by improving cell mobilization

Breakthrough discovery could boost stem-cell transplants by improving cell mobilization

Review of fasting-mimicking diets in cancer treatment

Review of fasting-mimicking diets in cancer treatment

Understanding the age gap in leukemia survival rates

Understanding the age gap in leukemia survival rates

Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

Rising cancer rates in younger generations signal urgent need for early-life prevention strategies

Rising cancer rates in younger generations signal urgent need for early-life prevention strategies

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

New prognostic marker identified for gastric cancer recurrence risk

New prognostic marker identified for gastric cancer recurrence risk

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Scientists explore early life factors contributing to SMA

Scientists explore early life factors contributing to SMA

Moffitt study identifies predictive biomarkers for immunotherapy in merkel cell carcinoma

Moffitt study identifies predictive biomarkers for immunotherapy in merkel cell carcinoma

Understanding Global Harmonization of Regulatory CMC within Veterinary Medicine with Tammy Newbold

Understanding Global Harmonization of Regulatory CMC within Veterinary Medicine with Tammy Newbold

Montana looks to become latest state to boost nonprofit hospital oversight

Montana looks to become latest state to boost nonprofit hospital oversight

Pesticide use in agriculture may pose cancer risks similar to smoking

Pesticide use in agriculture may pose cancer risks similar to smoking

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.